NxThera Raises $21.6 Million in Series B Financing
10/5/2011 8:26:14 AM
St. Paul, Minnesota-based medical device company NxThera, Inc. has raised $21.6 million in series B equity financing, the company announced today. (A percentage of the money raised will be funded after certain milestones are met.) Funds raised will be used to obtain European CE Mark approval and U.S. Food and Drug Administration clearance for a clinical study for the Rezum vapor ablation device in Europe, Canada and the United States, and to develop additional endourology devices.